CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,687,000 | +4.5% | 66,911 | +15.6% | 0.00% | 0.0% |
| Q1 2015 | $1,614,000 | +67.1% | 57,901 | +9.4% | 0.00% | 0.0% |
| Q4 2014 | $966,000 | +142.1% | 52,914 | +71.8% | 0.00% | – |
| Q3 2014 | $399,000 | +0.3% | 30,801 | +26.3% | 0.00% | – |
| Q2 2014 | $398,000 | -47.4% | 24,381 | -43.1% | 0.00% | -100.0% |
| Q1 2014 | $757,000 | -29.7% | 42,883 | -3.7% | 0.00% | 0.0% |
| Q4 2013 | $1,077,000 | +47.5% | 44,509 | +116.0% | 0.00% | 0.0% |
| Q3 2013 | $730,000 | – | 20,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |